Related Experiment Video
Updated: Feb 16, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Innovative Approaches to Increase Access to Medicines in Developing Countries.
Hilde Stevens1, Isabelle Huys2
1Institute for Interdisciplinary Innovation in healthcare (I3h), Unversité libre de Bruxelles (ULB), Brussels, Belgium.
Access to essential medicines remains a global challenge, with high prices hindering availability, especially in low-income nations. Innovative partnerships and technology transfer are crucial for affordable medicine distribution worldwide.
Area of Science:
- Global Health
- Pharmaceutical Policy
- Health Economics
Background:
- One-third of the global population faces challenges accessing essential medicines.
- High medicine prices are a significant barrier, particularly in least-developed and middle-income countries.
- Existing healthcare disparities are exacerbated by unaffordable essential drugs, vaccines, and diagnostics.
Purpose of the Study:
- To explore innovative strategies for improving global access to essential medicines.
- To identify key factors in stimulating innovation and promoting healthcare delivery.
- To address the challenge of making essential medicines affordable and accessible in low- and middle-income countries (LMICs).
Main Methods:
- Analysis of innovative approaches based on partnerships, intellectual property, and pricing strategies.
- Review of existing models for stimulating pharmaceutical innovation.
- Examination of healthcare delivery and global health disparity reduction initiatives.
Main Results:
- No single approach effectively addresses the complex issue of medicine accessibility.
- Partnerships, intellectual property, and pricing models show potential but require further development.
- Knowledge and technology transfer are identified as critical components for progress.
Conclusions:
- Multi-faceted strategies involving diverse stakeholders are necessary for ensuring medicine access.
- Enhanced partnerships are vital for facilitating the manufacturing, authorization, and distribution of medicines in LMICs.
- Sustainable solutions require a focus on affordable and acceptable conditions for essential medicine availability.
Related Concept Videos
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Bioavailability Enhancement: Drug Permeability Enhancement
Oral Drug Delivery Systems: Introduction
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

